Abstract
Awareness of cognitive deficits and clinical competence were investigated in 79 mild to moderate Alzheimer’s disease patients. Awareness was assessed by the anosognosia questionnaire for dementia, and clinical competence by specific neuropsychological tests such as trail making test-A, Babcock story recall test, semantic and phonemic verbal fluency. The findings show that 66 % of the patients were aware of memory deficits, while the 34 % were unaware. Deficit in awareness correlated with lower scores on the Mini Mental State Examination test that, in the score range from 24.51 to 30 and from 19.50 to 24.50, appeared to be a significant predictor of level of awareness. None of the AD patients had fully preserved clinical competence, only 7 patients (9 %) had partially preserved clinical competence and 72 patients (91 %) had completely lost clinical competence. All the patients with partially preserved clinical competence (9 %) were aware of their memory deficit. The study indicates that neuropsychological tests used for the assessment of executive functions are not suitable for investigating clinical competence. Therefore, additional and specific tools for the evaluation of clinical competence are necessary. Indeed, these might allow clinicians to identify AD patients who, despite their deficits in selected functions, retain their autonomy of choice as well as recognize those patients who should proceed to the nomination of a legal representative.
Similar content being viewed by others
References
Starkstein SE, Power BD (2010) Anosognosia in Alzheimer’s disease: neuroimaging correlates. In: Prigatano GP (ed) The study of anosognosia. Oxford University Press, New York, pp 171–187
Antoine C, Antoine P, Guermonprez P, Frigard B (2004) Awareness of deficits and anosognosia in Alzheimer's disease. Encephale 30(6):570–577
Prigatano GP (ed) (2010) The study of anosognosia. Oxford University Press, New York
Orfei MD, Robinson RG, Bria P et al (2008) Unawareness of illness in neuropsychiatric disorders: phenomenological certainty versus etiopathogenic vagueness. Neuroscientist 14(2):203–222
Orfei MD, Varsi AE et al (2010) Anosognosia in mild cognitive impairment and mild Alzheimer’s disease: frequency and neuropsychological correlates. Am J Geriatr Psychiatry 18:1133–1140
Agnew SK, Morris RG (1998) The heterogeneity of anosognosia for memory impairment in Alzheimer’s disease: a review of the literature and a proposed model. Aging Ment Health 2:9–15
Salmon E, Perani D, Herholz K et al (2006) Neural correlates of anosognosia for cognitive impairment in Alzheimer’s disease. Hum Brain Mapp 27(7):588–597
Amanzio M, Torta DM, Sacco K et al (2011) Unawareness of deficits in Alzheimer’s disease: role of the cingulate cortex. Brain 134:1061–1076
Spalletta G, Girardi P, Caltagirone C, Orfei MD (2012) Anosognosia and neuropsychiatric symptoms and disorders in mild Alzheimer disease and mild cognitive impairment. J Alzheimer Dis 29(4):761–772
Vogel A, Hasselbakch SG, Gade A et al (2005) Cognitive and functional neuroimaging correlate for anosognosia in mild cognitive impairment and Alzheimer’s disease. Int J Geriatr Psychiatry 20(3):238–246
Appelbaum PS (2007) Assessment of patients’ competence to consent to treatment. N Engl J Med 357:1834–1840
Kashiwa Y, Kitabayashi Y, Narumoto J et al (2005) Anosognosia in Alzheimer’s disease: association with patient characteristics, psychiatric symptoms and cognitive deficits. Psychiatry Clin Neurosci 59:697–704
McKahnn G, Drachman D, Folstein M et al (1984) Clinical diagnosis of Alzheimer’s disease: report of NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Service Task Force on Alzheimer’s Disease. Neurology 34:939–944
Dubois B, Feldman HH, Jacova C et al (2007) Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 6(8):734–746
Carlesimo GA, Caltagirone C, Gainotti G et al (1996) The mental deterioration battery: normative data, diagnostic reliability and qualitative analysis of cognitive impairment. The group for the standardization of mental deterioration battery. Eur Neurol 36:378–384
Lawton MP, Brody EM (1969) Assessment of older people: self -maintaining and instrumental activities of daily living. Gerontologist 9:179–186
Katz S, Ford AB, Moskowitz RW et al (1963) Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychological function. JAMA 185:914–919
Folstein MF, Folstein SE, McHugh PR (1975) Mini mental state: a practical method for grading the cognitive state of patients for clinician. J Psychiatr Res 12:189–198
Yesavage JA, Brink TL, Rose TL et al (1983) Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 17(1):37–49
Starkstein SE, Jorge R, Mizrahi R et al (2006) A diagnostic formulation for anosognosia in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 77:719–725
Petrini C (2008) Il consenso informato al trattamento dei soggetti affetti da demenza: aspetti etici, deontologici e giuridici. Roma, Istituto Superiore di Sanità, Rapporti ISTISAN 08/03
Carlesimo GA, Buccione I, Fadda L et al (2002) Standardizzazione di due test di memoria per uso clinico: breve racconto e figura di Rey. Nuova Rivista di Neurologia 12:1–13
Giovagnoli AR, Del Pesce M, Mascheroni S et al (1996) Trail making test: normative values from 287 normal adult controls. Ital J Neurol Sci 17:305–309
Marson DC, Hawkins LBS, MsInturff BBS, Harrell LE (1997) Cognitive models that predict physician judgements of capacity to consent in mild Alzheimer’s disease. JAGS 45:458–464
Kaszniak AW, Edmonds EC (2010) Anosognosia and Alzheimer’s disease: behavioral studies. In: Prigatano GP (ed) The study of anosognosia. Oxford University Press, New York, pp 189–227
Reed BR, Jagust WJ, Coulter L (1993) Anosognosia in Alzheimer’s disease: relationships to depression, cognitive function and cerebral perfusion. J Clin Exp Neuropsychol 15(2):231–244
Stewart G, McGeown WJ, Shanks MF, Venneri A (2010) Anosognosia for memory impairment in Alzheimer’s disease. Acta Neuropsychiatrica 22:180–187
McDaniel KD, Edland SD, Heyman A (1995) Relationship between level of insight and severity of dementia in Alzheimer disease. CERAD clinical investigators. Consortium to establish a registry for Alzheimer’s disease. Alzheimer Dis Assoc Disord 9(2):101–104
Sullivan K (2004) Neuropsychological assessment of mental capacity. Neuropsychol Rev 14:131–142
Kim SYH, Caine ED, Currier GW et al (2001) Assessing the competence of persons with Alzheimer’s disease in providing informed consent for participation in research. Am J Psychiatry 158:712–717
Dunn LB, Milap A, Nowrangi MB, Barton W et al (2006) Assessing decisional capacity for clinical research or treatment: a review of instruments. Am J Psychiatry 163:1323–1334
Galeotti F, Vanacore N, Gainotti S, Ad Care Study Group et al (2012) How legislation on decisional capacity can negatively affect the feasibility of clinical trials in patients with dementia. Drugs Aging 29(8):607–614
Crosson C, Barco P, Velozo C et al (1989) Awareness and compensation in post acute head injury rehabilitation. J Head Trauma Rehabil 4:46–54
Moro V, Pernigo S, Cordioli Z et al (2011) Phenomenology and neural correlates of implicit and emergent motor awareness in patients with anosognosia for hemiplegia. Behav Brain Res 225(1):259
Lui V, Lam L, Luk D et al (2009) Capacity to make treatment decision in Chinese older persons with very mild dementia and mild Alzheimer’s disease. Am J Geriatr Psychiatry 17:428–436
Acknowledgments
We would like to thank Annalena Venneri, Giulia Bisoffi, Giosuè Gulli for their support and for their useful comments regarding the versions of manuscript. This study was supporting by Cariverona Foundation (Disabilità cognitive e comportamentali nelle demenze e nelle psicosi - Progetto Neuroscienze, Prot. N. 1855, 2009–2013)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gambina, G., Bonazzi, A., Valbusa, V. et al. Awareness of cognitive deficits and clinical competence in mild to moderate Alzheimer’s disease: their relevance in clinical practice. Neurol Sci 35, 385–390 (2014). https://doi.org/10.1007/s10072-013-1523-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-013-1523-5